Neel U. Sukhatme is an Associate Professor of Law at Georgetown University Law Center and Thomas Alva Edison Visiting Scholar at the U.S. Patent and Trademark Office. Neel received his Ph.D. in Economics from Princeton University, where he was awarded the 2014 Towbes Prize for Outstanding Teaching. He received his J.D., cum laude, from Harvard Law School, where he served as Notes Editor of the Harvard Law Review. After law school, Neel clerked for the Hon. Vaughn R. Walker on the U.S. District Court for the Northern District of California and the Hon. Ann Claire Williams on the U.S. Court of Appeals for the Seventh Circuit.
Neel is licensed to practice law in Illinois (inactive) and California, and he previously worked at Latham & Watkins LLP. He received his Bachelor’s Degree in Computer Engineering (highest honors) with a minor in Mathematics from the University of Illinois. Neel relies on his technical background as lead programmer and patent counsel for Spindrop, a music technology startup that he co-founded in 2010.
Neel has published or forthcoming articles in the Harvard Law Review, Cornell Law Review, Minnesota Law Review, American Law and Economics Review, William & Mary Law Review, Washington and Lee Law Review, Houston Law Review, Harvard International Law Journal, and Competition Policy International. His current research focuses on empirical patent law and law and economics. He teaches Property, Patent Law, Corporate Finance, and Empirical Analysis for Lawyers and Policymakers, and he co-directs the Georgetown Law and Economics Workshop series.
Contributions to Law Reviews and Other Scholarly Journals
"Using Rigorous Policy Pilots to Improve Governance," an opinion piece co-authored by Professor Neel U. Sukhatme, appearing in The Regulatory Review, November 19, 2019.
"Health Policy’s Gordian Knot: Rethinking Cost Control," a piece co-authored by Professors M. Gregg Bloche and Neel U. Sukhatme, appearing in Health Affairs, April 26, 2017.
"Why is the government allowing its own drug research to be monopolized for profit?," coverage in The Week Magazine, March 28, 2019, featuring Associate Professor Neel U. Sukhatme.
"An HIV treatment cost taxpayers millions. The government patented it. But a pharma giant is making billions," coverage by the Washington Post, March 26, 2019, quoting Professor Neel U. Sukhatme.